Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Nov;85(11):1611–1618. doi: 10.1054/bjoc.2001.2090

Neurodevelopment of children exposed in utero to treatment of maternal malignancy

I Nulman 1,2,3,4, D Laslo 1, S Fried 4, E Uleryk 3, M Lishner 1, G Koren 1,2,3,4
PMCID: PMC2363995  PMID: 11742476

Abstract

Cancer is the second most common cause of death during the reproductive years, complicating approximately 1/1000 pregnancies. The occurrence of cancer during gestation is likely to increase as a result of a woman's tendency to delay childbearing. Improved diagnostic techniques for malignancies increases detection of cancer during pregnancy. Malignant conditions during gestation are believed to be associated with an increase in poor perinatal and fetal outcomes that are often due to maternal treatment. Physicians should weigh the benefits of treatment against the risks of fetal exposure. To date, most reports have focused on morphologic observations made very close to the time of delivery with little data collected on children's long-term neurodevelopment following in utero exposure to malignancy and treatment. Because the brain differentiates throughout pregnancy and in early postnatal life, damage may occur even after first trimester exposure. The possible delayed effects of treatment on a child's neurological, intellectual and behavioural functioning have never been systematically evaluated. The goal of this report was to summarize all related issues into one review to facilitate both practitioners' and patients' access to known data on fetal risks and safety. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: malignancy, child development, antineoplastic medications, radiation, glucocorticoids, bromocriptine

Full Text

The Full Text of this article is available as a PDF (77.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angelucci L., Patacchioli F. R., Scaccianoce S., Di Sciullo A., Cardillo A., Maccari S. A model for later-life effects of perinatal drug exposure: maternal hormone mediation. Neurobehav Toxicol Teratol. 1985 Sep-Oct;7(5):511–517. [PubMed] [Google Scholar]
  2. Avilés A., Niz J. Long-term follow-up of children born to mothers with acute leukemia during pregnancy. Med Pediatr Oncol. 1988;16(1):3–6. doi: 10.1002/mpo.2950160102. [DOI] [PubMed] [Google Scholar]
  3. Avilés A., Zepeda G., Cruz J. Enfermedad de Hodgkin durante el embarazo. Estudio de efectos tardíos en los recién nacidos. Bol Med Hosp Infant Mex. 1991 Sep;48(9):622–626. [PubMed] [Google Scholar]
  4. Baisogolov G. D., Shishkin I. P. Techenie beremennosti i sostoianie rodivshikhsia detei u bol'nykh, lechennykh po povodu limfogranulematoza. Med Radiol (Mosk) 1985 May;30(5):35–37. [PubMed] [Google Scholar]
  5. Balcewicz-Sablińska K., Cieśluk S., Kopeć I., Słomkowski M., Maj S. Analiza ciaz, porodów, urodzonych dzieci i przebiegu choroby u kobiet chorych na ziarnice złośliwa. Acta Haematol Pol. 1990 Jan-Jun;21(1):72–80. [PubMed] [Google Scholar]
  6. Blatt J., Mulvihill J. J., Ziegler J. L., Young R. C., Poplack D. G. Pregnancy outcome following cancer chemotherapy. Am J Med. 1980 Dec;69(6):828–832. doi: 10.1016/s0002-9343(80)80007-6. [DOI] [PubMed] [Google Scholar]
  7. Brent R. L. Radiation teratogenesis. Teratology. 1980 Jun;21(3):281–298. doi: 10.1002/tera.1420210304. [DOI] [PubMed] [Google Scholar]
  8. Brown J. E., Jacobson H. N., Askue L. H., Peick M. G. Influence of pregnancy weight gain on the size of infants born to underweight women. Obstet Gynecol. 1981 Jan;57(1):13–17. [PubMed] [Google Scholar]
  9. Caligiuri M. A., Mayer R. J. Pregnancy and leukemia. Semin Oncol. 1989 Oct;16(5):388–396. [PubMed] [Google Scholar]
  10. Cantini E., Yanes B. Acute myelogenous leukemia in pregnancy. South Med J. 1984 Aug;77(8):1050–1052. doi: 10.1097/00007611-198408000-00032. [DOI] [PubMed] [Google Scholar]
  11. Chambers C. D., Johnson K. A., Dick L. M., Felix R. J., Jones K. L. Maternal fever and birth outcome: a prospective study. Teratology. 1998 Dec;58(6):251–257. doi: 10.1002/(SICI)1096-9926(199812)58:6<251::AID-TERA6>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
  12. Clarren S. K., Smith D. W., Harvey M. A., Ward R. H., Myrianthopoulos N. C. Hyperthermia--a prospective evaluation of a possible teratogenic agent in man. J Pediatr. 1979 Jul;95(1):81–83. doi: 10.1016/s0022-3476(79)80092-x. [DOI] [PubMed] [Google Scholar]
  13. Dekaban A. S. Abnormalities in children exposed to x-radiation during various stages of gestation: tentative timetable of radiation injury to the human fetus. I. J Nucl Med. 1968 Sep;9(9):471–477. [PubMed] [Google Scholar]
  14. Doll D. C., Ringenberg Q. S., Yarbro J. W. Management of cancer during pregnancy. Arch Intern Med. 1988 Sep;148(9):2058–2064. [PubMed] [Google Scholar]
  15. French N. P., Hagan R., Evans S. F., Godfrey M., Newnham J. P. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol. 1999 Jan;180(1 Pt 1):114–121. doi: 10.1016/s0002-9378(99)70160-2. [DOI] [PubMed] [Google Scholar]
  16. Friedman J. M. Teratogen update: anesthetic agents. Teratology. 1988 Jan;37(1):69–77. doi: 10.1002/tera.1420370111. [DOI] [PubMed] [Google Scholar]
  17. Gililland J., Weinstein L. The effects of cancer chemotherapeutic agents on the developing fetus. Obstet Gynecol Surv. 1983 Jan;38(1):6–13. [PubMed] [Google Scholar]
  18. Granroth G. Defects of the central nervous system in Finland. IV. Associations with diagnostic x-ray examinations. Am J Obstet Gynecol. 1979 Jan 15;133(2):191–194. doi: 10.1016/0002-9378(79)90474-5. [DOI] [PubMed] [Google Scholar]
  19. Harada M. Congenital Minamata disease: intrauterine methylmercury poisoning. Teratology. 1978 Oct;18(2):285–288. doi: 10.1002/tera.1420180216. [DOI] [PubMed] [Google Scholar]
  20. Hoel D. G. Radiation risk estimation models. Environ Health Perspect. 1987 Nov;75:105–107. doi: 10.1289/ehp.8775105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Jensh R. P., Brent R. L. Effects of 0.6-Gy prenatal X irradiation on postnatal neurophysiologic development in the Wistar rat. Proc Soc Exp Biol Med. 1986 Apr;181(4):611–619. doi: 10.3181/00379727-181-42299. [DOI] [PubMed] [Google Scholar]
  22. Jensh R. P., Brent R. L. The effect of low-level prenatal X-irradiation on postnatal development in the Wistar rat. Proc Soc Exp Biol Med. 1987 Mar;184(3):256–263. doi: 10.3181/00379727-184-42476. [DOI] [PubMed] [Google Scholar]
  23. Konopka P., Raymond J. P., Merceron R. E., Seneze J. Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas. Am J Obstet Gynecol. 1983 Aug 15;146(8):935–938. doi: 10.1016/0002-9378(83)90968-7. [DOI] [PubMed] [Google Scholar]
  24. Kozlowski R. D., Steinbrunner J. V., MacKenzie A. H., Clough J. D., Wilke W. S., Segal A. M. Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am J Med. 1990 Jun;88(6):589–592. doi: 10.1016/0002-9343(90)90522-f. [DOI] [PubMed] [Google Scholar]
  25. Källén B., Mazze R. I. Neural tube defects and first trimester operations. Teratology. 1990 Jun;41(6):717–720. doi: 10.1002/tera.1420410608. [DOI] [PubMed] [Google Scholar]
  26. Layde P. M., Edmonds L. D., Erickson J. D. Maternal fever and neural tube defects. Teratology. 1980 Feb;21(1):105–108. doi: 10.1002/tera.1420210114. [DOI] [PubMed] [Google Scholar]
  27. MacArthur B. A., Howie R. N., Dezoete J. A., Elkins J. School progress and cognitive development of 6-year-old children whose mothers were treated antenatally with betamethasone. Pediatrics. 1982 Jul;70(1):99–105. [PubMed] [Google Scholar]
  28. Meaney M. J., Stewart J., Beatty W. W. The influence of glucocorticoids during the neonatal period on the development of play-fighting in Norway rat pups. Horm Behav. 1982 Dec;16(4):475–491. doi: 10.1016/0018-506x(82)90054-x. [DOI] [PubMed] [Google Scholar]
  29. Medková J. Analysis of the health condition of the children born to the personnel exposed to cytostatics at an oncology unit. Acta Univ Palacki Olomuc Fac Med. 1991;130:323–332. [PubMed] [Google Scholar]
  30. Metcoff J., Costiloe J. P., Crosby W., Bentle L., Seshachalam D., Sandstead H. H., Bodwell C. E., Weaver F., McClain P. Maternal nutrition and fetal outcome. Am J Clin Nutr. 1981 Apr;34(Suppl 4):708–721. doi: 10.1093/ajcn/34.4.708. [DOI] [PubMed] [Google Scholar]
  31. Miller P., Smith D. W., Shepard T. H. Maternal hyperthermia as a possible cause of anencephaly. Lancet. 1978 Mar 11;1(8063):519–521. doi: 10.1016/s0140-6736(78)90549-4. [DOI] [PubMed] [Google Scholar]
  32. Nader S. Pituitary disorders and pregnancy. Semin Perinatol. 1990 Feb;14(1):24–33. [PubMed] [Google Scholar]
  33. Naeye R. L., Chez R. A. Effects of maternal acetonuria and low pregnancy weight gain on children's psychomotor development. Am J Obstet Gynecol. 1981 Jan 15;139(2):189–193. doi: 10.1016/0002-9378(81)90444-0. [DOI] [PubMed] [Google Scholar]
  34. Odom L. D., Plouffe L., Jr, Butler W. J. 5-fluorouracil exposure during the period of conception: report on two cases. Am J Obstet Gynecol. 1990 Jul;163(1 Pt 1):76–77. doi: 10.1016/s0002-9378(11)90672-3. [DOI] [PubMed] [Google Scholar]
  35. Otake M., Schull W. J. In utero exposure to A-bomb radiation and mental retardation; a reassessment. Br J Radiol. 1984 May;57(677):409–414. doi: 10.1259/0007-1285-57-677-409. [DOI] [PubMed] [Google Scholar]
  36. Potter J. F., Schoeneman M. Metastasis of maternal cancer to the placenta and fetus. Cancer. 1970 Feb;25(2):380–388. doi: 10.1002/1097-0142(197002)25:2<380::aid-cncr2820250216>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  37. Reynoso E. E., Shepherd F. A., Messner H. A., Farquharson H. A., Garvey M. B., Baker M. A. Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. J Clin Oncol. 1987 Jul;5(7):1098–1106. doi: 10.1200/JCO.1987.5.7.1098. [DOI] [PubMed] [Google Scholar]
  38. Schull W. J., Norton S., Jensh R. P. Ionizing radiation and the developing brain. Neurotoxicol Teratol. 1990 May-Jun;12(3):249–260. doi: 10.1016/0892-0362(90)90096-u. [DOI] [PubMed] [Google Scholar]
  39. Stein Z., Susser M., Saenger G., Marolla F. Nutrition and mental performance. Science. 1972 Nov 17;178(4062):708–713. doi: 10.1126/science.178.4062.708. [DOI] [PubMed] [Google Scholar]
  40. Sylvester G. C., Khoury M. J., Lu X., Erickson J. D. First-trimester anesthesia exposure and the risk of central nervous system defects: a population-based case-control study. Am J Public Health. 1994 Nov;84(11):1757–1760. doi: 10.2105/ajph.84.11.1757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Tincani A., Faden D., Tarantini M., Lojacono A., Tanzi P., Gastaldi A., Di Mario C., Spatola L., Cattaneo R., Balestrieri G. Systemic lupus erythematosus and pregnancy: a prospective study. Clin Exp Rheumatol. 1992 Sep-Oct;10(5):439–446. [PubMed] [Google Scholar]
  42. Trautman P. D., Meyer-Bahlburg H. F., Postelnek J., New M. I. Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study. Psychoneuroendocrinology. 1995;20(4):439–449. doi: 10.1016/0306-4530(94)00070-0. [DOI] [PubMed] [Google Scholar]
  43. Turkalj I., Braun P., Krupp P. Surveillance of bromocriptine in pregnancy. JAMA. 1982 Mar 19;247(11):1589–1591. [PubMed] [Google Scholar]
  44. Veszelovszky I., Farkasinszky T., Nagy Z., Bódis L., Szilárd J. Dexamethasonnal kezelt anyák gyermekeinek pszichés és neuroszomatikus utóvizsgálata. Orv Hetil. 1981 Mar 15;122(11):629–631. [PubMed] [Google Scholar]
  45. Wagoner L. E., Taylor D. O., Olsen S. L., Price G. D., Sr, Rasmussen L. G., Larsen C. B., Scott J. R., Renlund D. G. Immunosuppressive therapy, management, and outcome of heart transplant recipients during pregnancy. J Heart Lung Transplant. 1993 Nov-Dec;12(6 Pt 1):993–1000. [PubMed] [Google Scholar]
  46. Webster W. S., Lipson A. H., Sulik K. K. Interference with gastrulation during the third week of pregnancy as a cause of some facial abnormalities and CNS defects. Am J Med Genet. 1988 Nov;31(3):505–512. doi: 10.1002/ajmg.1320310304. [DOI] [PubMed] [Google Scholar]
  47. Woo S. Y., Fuller L. M., Cundiff J. H., Bondy M. L., Hagemeister F. B., McLaughlin P., Velasquez W. S., Swan F., Jr, Rodriguez M. A., Cabanillas F. Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin's disease. Int J Radiat Oncol Biol Phys. 1992;23(2):407–412. doi: 10.1016/0360-3016(92)90761-6. [DOI] [PubMed] [Google Scholar]
  48. Yoshimaru H., Otake M., Fujikoshi Y., Schull W. J. [Effect on school performance of prenatal exposure to the Hiroshima atomic bomb]. Nihon Eiseigaku Zasshi. 1991 Aug;46(3):747–754. doi: 10.1265/jjh.46.747. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES